16-Apr-15 Moody's Investors Service says that continued strong growth in China's pharmaceutical sector will mainly benefit those pharmaceutical companies that can meet heightened industry standards and market practices under the ongoing medical reform. [image: Language Connections]

15-Apr-15 Chinese trade officials said recently China will streamline regulations on the entry of medical devices and pharmaceuticals from the United States. The promises from Chinese regulators about the medical device and pharmaceutical industries are expected to lead to an increase in US exports and US jobs in these two sectors. [image: Securing Industry]

08-Apr-15 According to a survey conducted by Shanghai Academy of Social Sciences and Fudan University, local residents identified long queues, unnecessary tests and expensive prescription medicines as the biggest problems with the city’s health services. [image: Shanghai Daily]

02-Apr-15 Pfizer Inc said it will cease vaccines sales in China after an import licence for the only vaccine it sold there was not renewed. Drug makers face growing difficulties obtaining approvals in the world’s no. 2 drug market, where pharmaceutical executives say regulators have added more red tape to the process of bringing drugs to market. [image: Fortune]

02-Apr-15 More private high-end hospitals have come to Shenzhen as its middle-class keeps expanding. The city is also reported to be encouraging private investment in the public health sector. “The city government has... included the hospital into the national health care insurance network to help patients reduce their costs,” said Liu Jiangning, executive president of C-Mer (Shenzhen) Dennis Law Eye Hospital. [image: Shenzhen Standard]